Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data

Effect of Clarithromycin in Inflammatory Markers of Patients with Ventilator-Associated Pneumonia and Sepsis Caused by Gram-Negative Bacteria: Results from a Randomized Clinical Study

(2012) Aikaterini Spyridaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

(2012) Leyla Asadi et al.   CLINICAL INFECTIOUS DISEASES

The immune response to severe bacterial infections: consequences for therapy

(2012) Evangelos J Giamarellos-Bourboulis et al.   Expert Review of Anti-Infective Therapy

Macrolides in the treatment of asthma

(2011) James T. Good et al.   CURRENT OPINION IN PULMONARY MEDICINE

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases

(2011) P. Zarogoulidis et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review

(2011) A. Kovaleva et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Clinical Predictive Value (or Lack Thereof) of the Results of In Vitro Antimicrobial Susceptibility Tests

(2011) G. V. Doern et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Guideline adherence and macrolides reduced mortality in outpatients with pneumonia

(2011) Leyla Asadi et al.   RESPIRATORY MEDICINE

Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention

(2009) Joseph Lynch et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of Clarithromycin in Patients with Sepsis and Ventilator‐Associated Pneumonia

(2008) Evangelos J. Giamarellos‐Bourboulis et al.   CLINICAL INFECTIOUS DISEASES